Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study

OBJECTIVE: To investigate the treatment efficacy of ultra-low-dose bevacizumab for cerebral radiation necrosis. METHODS: Patients with cerebral radiation necrosis after stereotactic radiotherapy (SRT) confirmed by imaging were included. Bevacizumab (1 mg/kg, once every three weeks, for at least thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Hongqing, Zhuang, Hongxia, Shi, Siyu, Wang, Yuxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792824/
https://www.ncbi.nlm.nih.gov/pubmed/31632089
http://dx.doi.org/10.2147/OTT.S223258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792824/
https://www.ncbi.nlm.nih.gov/pubmed/31632089
http://dx.doi.org/10.2147/OTT.S223258

Ejemplares similares